THE ASSESMENT EFFECTIVENESS OF ANTIARRHYTHMIC THERAPY WITH AMIODARONE OF ATRIAL FIBRILLATION PAROXYSMS AT THE PREHOSPITAL STAGE IN DIFFERENT PATIENTS AGE GROUPS
https://doi.org/10.24884/2072-6716-2019-20-1-30-34
Abstract
A retrospective content analysis of 210 emergency medical call cards with paroxysms of atrial fibrillation up to 48 hours was carried out in order to analyze and improve the algorithm of prehospital therapy of emergency arrhythmias based on the study of the peculiarities of amiodarone action in elderly and young patients in emergency care.
About the Authors
I. G. Truhanova
Samara State Medical University, Samara
Russian Federation
Russian Federation
D. S. Zinatullina
Samara State Medical University, Samara
Russian Federation
Russian Federation
I. A. Polyakov
Samara State Medical University, Samara
Russian Federation
Russian Federation
S. H. Sadreeva
Samara State Medical University, Samara
Russian Federation
Russian Federation
References
1. 2016 ESC guildelines for the management of atrial fibrillation developed in collaboration with EACTS. European Society of Cardiology (ESC). European Heart Rhythm Association (EHRA) of the ESC // Eur. Heart J. 2016. Vol. 37 (38). Р. 2893–2962. doi: https://doi.org/10.1093/eurheartj/ehw210.
2. Clinical recommendations for the diagnosis and treatment of atrial fibrillation. Russian Cardiology Society. All-Russian Scientific Society of Clinical Electrophysiology, Arrhythmology and Pacemakers, Association of Cardiovascular Surgeons. 2017 (in Russ.)
3. Shljahto E. V. Cardiology: national guidelines. 2nd еd., rev. and extra. Moscow: Izdatel’stvo GEOTAR-Media, 2015, 800 р. (in Russ)
4. Filatov A. G., Tarashvili Je.G.. Epidemiology and social significance of atrial fibrillation. Annaly aritmologii, 2012, No 2 (64), рр. 5–13 (In Russ)
5. Kolbin A. S., Mosikyan A. A., Tatarsky B. A. Socioeconomic burden of atrial fibrillations in Russia: Seven-year trends (2010–2017). Vestnik aritmologii, 2018, No 92, рр. 42–48. doi: 10.25760/VA-2018–92– 42–48 (in Russ.)
6. Chugh S.S., Havmoeller R., Narayanan K., Singh D., Rienstra M., Benjamin E. J. et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study // Circulation. 2014. Vol. 25, No 129 (8). Р. 837–847. doi: 0.1161/CIRCULATIONAHA.113.005119.
7. Khan I.A., Mehta N. J., Gowda R. M. Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillation // Int. J. Cardiol. 2003. Vol. 89. P. 239–248.
8. Trappe H. J. Treating critical supraventricular and ventricular arrhythmias // J. Emerg. Trauma Shock. 2010. Vol. 3 (2). Р. 143–152. doi: 10.4103/0974–2700.62114.
9. Miller O. N., Beljalov F. I. Ftrial fibrillation. Clinical management of patients pre-hospital, inpatient and outpatient. Rossijskij kardiologicheskij zhurnal, 2009, Nо 4, рр. 94–111 (in Russ)
10. Meraj I. A., Pavlikova E. P., Aleksandrija L. G., Teraz Ja. M. Potassium and magnesium Asparaginate in the restoration and preservation of sinus rhythm in patients with a stable form of atrial fibrillation. Consilium Medicum, 2007, No 11, рр. 81–83 (in Russ)
Review
For citations:
Truhanova I.G., Zinatullina D.S., Polyakov I.A., Sadreeva S.H. THE ASSESMENT EFFECTIVENESS OF ANTIARRHYTHMIC THERAPY WITH AMIODARONE OF ATRIAL FIBRILLATION PAROXYSMS AT THE PREHOSPITAL STAGE IN DIFFERENT PATIENTS AGE GROUPS. EMERGENCY MEDICAL CARE. 2019;20(1):30-34. (In Russ.) https://doi.org/10.24884/2072-6716-2019-20-1-30-34
Views:
583
Email this article 